These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 228408)

  • 21. Penicillamine in rheumatoid arthritis: adverse effects.
    Hill HF
    Scand J Rheumatol Suppl; 1979; (28):94-9. PubMed ID: 156393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of rheumatoid arthritis associated with leukocytopenia during D-penicillamine treatment].
    Negishi M; Sato H; Sekine F; Mita S; Ono I; Kobayashi K; Oseto Y; Hamai T; Takahashi T
    Arerugi; 1982 Jun; 31(6):350-4. PubMed ID: 7181659
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: D-penicillamine in rheumatoid arthritis.
    Lancet; 1975 May; 1(7916):1123-5. PubMed ID: 49477
    [No Abstract]   [Full Text] [Related]  

  • 24. [D-penicillamine in various diseases in childhood (author's transl)].
    Weingärtner L
    Med Klin; 1979 Jun; 74(26):1038-42. PubMed ID: 460039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evans' syndrome caused by D-penicillamine in rheumatoid arthritis. Value of the corticoids-danazol combination].
    Masson C; Brégeon C; Ifrah N; Berton V; Housseau F; Rénier JC
    Rev Rhum Mal Osteoartic; 1991; 58(7):519-22. PubMed ID: 1925397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment].
    Benveniste M; Crouzet J; Homberg JC; Lessana M; Camus JP; Hewitt J
    Nouv Presse Med; 1975 Dec; 4(44):3125-8. PubMed ID: 1220709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic efficiency of penicillamine D in rheumatic arthritis].
    Robles Gil J
    Arch Inst Cardiol Mex; 1979; 49(4):685-91. PubMed ID: 485674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Actual results of the rheumatoid polyarthritis therapy with immuno-suppressive drugs: d-penicillamine and cytostatics (author's transl)].
    Barnes CG
    Schweiz Rundsch Med Prax; 1977 Nov; 66(44):1412-20. PubMed ID: 928306
    [No Abstract]   [Full Text] [Related]  

  • 31. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
    Davis P; Bleehen SS
    Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821
    [No Abstract]   [Full Text] [Related]  

  • 32. [D-penicillamine].
    Huskisson EC
    Reumatizam; 1976; 23(5):163-75. PubMed ID: 981828
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuromuscular complications of D-penicillamine in rheumatoid arthritis].
    Dubost JJ; Soubrier M; Bouchet F; Kemeny JL; Lhopitaux R; Bussière JL; Sauvezie B
    Rev Neurol (Paris); 1992; 148(3):207-11. PubMed ID: 1604135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [5-year treatment of rheumatoid polyarthritis with D-penicillamine].
    Duquesnoy B; Cocheteux P; Siame JL; Delcambre B
    Sem Hop; 1983 May; 59(21):1641-4. PubMed ID: 6310780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-related nephrotic syndrome in penicillamine-treated rheumatoid arthritis.
    Spiera H
    Mt Sinai J Med; 1984 Dec; 51(6):695-6. PubMed ID: 6335562
    [No Abstract]   [Full Text] [Related]  

  • 37. [Our experience with D penicillamine in the treatment of rheumatoid polyarthritis].
    D'Eshougues JR; Delcambre B; Siame JL; Barbot V; Brion M; Duquesnoy B; Alsac J; Dulieu R
    Lille Med; 1978 Apr; 23(4):259-63. PubMed ID: 651557
    [No Abstract]   [Full Text] [Related]  

  • 38. [100 cases of common rheumatoid polyarthritis, treated with D-penicillamin].
    Camus JP; Crouzet J; Guillien P; Benichou C; Lievre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):9-28. PubMed ID: 4603018
    [No Abstract]   [Full Text] [Related]  

  • 39. [Severe side-effects of treatment with D-penicillamine (author's transl)].
    Hennemann HH; Hubertus H; Stocker WG
    Dtsch Med Wochenschr; 1975 Aug; 100(32):1634-8. PubMed ID: 1172464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicity to D-penicillamine in rheumatoid arthritis.
    Magnus JH; Gran JT; Mikkelsen K; Nygaard H; Brath HK
    Scand J Rheumatol; 1987; 16(6):441-4. PubMed ID: 2962277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.